References
- Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020. doi:10.1016/s0140-6736(20)30251-8.
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020. doi:10.1016/s0140-6736(20)30211-7.
- Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. New England Journal of Medicine. 2020. doi:10.1056/nejmoa2001316.
- Munster VJ, Koopmans M, Doremalen NV, Riel DV, Wit ED. A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment. New England Journal of Medicine. 2020. doi:10.1056/nejmp2000929.
- Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (2019-NCoV) Infection Is Suspected Interim Guidance. World Health Organization; 2020. htps://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020. doi:10.1016/s0140-6736(20)30183-5.